Elke Theander

机构：Janssen (Belgium), Lund University, Janssen (Switzerland), Skåne University Hospital · ORCID：0000-0002-6533-2263

发表论文 187 篇 · 总被引 9447 次 · h-index 45

代表论文

• Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (2022 · Nature Communications · 被引 114)
• Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS) (2021 · Annals of the Rheumatic Diseases · 被引 106)
• Persistence of biologic treatments in psoriatic arthritis: a population-based study in Sweden (2020 · Rheumatology Advances in Practice · 被引 46)
• OUP accepted manuscript (2020 · Lara D. Veeken · 被引 41)
• Concomitant Ro/ SSA and La/ SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome (2019 · Journal of Internal Medicine · 被引 41)
• Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results (2021 · Annals of the Rheumatic Diseases · 被引 35)